Diabetes Clinical Trials in Atlanta, GA

67 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Peanuts for Cardiometabolic, Brain, and Intestinal Health	N/A	Georgia State University	<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes	Phase 2	SAb Biotherapeutics, Inc.	<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	<1 mi
TrialNet Pathway to Prevention of T1D	—	University of South Florida	<1 mi
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM	N/A	i-SENS, Inc.	<1 mi
CARE-D-FOOT-Nav Pilot	N/A	Emory University	<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	<1 mi
Bionic Pancreas in CFRD	Phase 3	Jaeb Center for Health Research	<1 mi
FEED-Cystic Fibrosis (FEED-CF)	N/A	Emory University	<1 mi
SPYRAL GEMINI Pilot Study	N/A	Medtronic Vascular	<1 mi
Study of WAL0921 in Patients With Glomerular Kidney Diseases	Phase 2	Walden Biosciences	<1 mi
Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation	N/A	Emory University	<1 mi
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity	Phase 4	Emory University	<1 mi
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure	N/A	Georgia State University	<1 mi
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	Phase 2	Pharming Technologies B.V.	<1 mi
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes	N/A	Georgia State University	<1 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes	Phase 3	Sanofi	<1 mi
Health Behavior Intervention for Adults With Type 1 Diabetes	N/A	Emory University	<1 mi
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes	N/A	Emory University	<1 mi
DFC 004 Biomarkers for Active Diabetic Foot Ulcers	—	University of Michigan	<1 mi
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)	—	Jaeb Center for Health Research	<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	<1 mi
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes	Phase 2	Eli Lilly and Company	<1 mi
Type 1 Diabetes Extension Study	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Long-Term Outcomes of Teplizumab in Routine Clinical Care	—	Sanofi	<1 mi
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System	N/A	Insulet Corporation	<1 mi
Thrive With Type 1 Diabetes 2026	N/A	Emory University	<1 mi
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	<1 mi
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study	—	Indiana University	<1 mi
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes	N/A	Insulet Corporation	<1 mi
Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management	N/A	Emory University	<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity	Phase 2	Antag Therapeutics	<1 mi
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes	Phase 3	Emory University	<1 mi
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)	Phase 3	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	<1 mi
Georgia CEAL RESTORES Family Diabetes Study	N/A	Morehouse School of Medicine	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	6 mi
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy	N/A	Jaeb Center for Health Research	6 mi
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes	Phase 3	Kailera	6 mi
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies	—	AstraZeneca	6 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	6 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes	Phase 3	Ascletis Pharma (China) Co., Limited	6 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin	Phase 3	AstraZeneca	6 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	12 mi
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications	Phase 3	Novo Nordisk A/S	12 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	12 mi
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.	Phase 4	Royal Biologics	13 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	Phase 3	Eli Lilly and Company	14 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	14 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	14 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide	Phase 2	Eli Lilly and Company	14 mi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes	Phase 3	Hoffmann-La Roche	14 mi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes	Phase 3	Hoffmann-La Roche	14 mi
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar	Phase 3	Boehringer Ingelheim	14 mi
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	17 mi
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	17 mi
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes	Phase 3	Kailera	17 mi
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	17 mi
Clinical Outcomes Related to Treatment of Distal Symmetric Polyneuropathy Using Semiconductor Embedded Therapeutic Socks	N/A	Endocrine Research Solutions	19 mi
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	19 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)	Phase 2/3	CSL Behring	21 mi
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus	Phase 2	Corxel Pharmaceuticals	21 mi
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes	Phase 4	Brigham and Women's Hospital	22 mi
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes	Phase 3	Novo Nordisk A/S	22 mi
Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students	N/A	Kennesaw State University	23 mi
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM	Phase 3	AstraZeneca	26 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.